Mirati Therapeutics
Why Robinhood?
You can watch MRTX and buy or sell other stocks, ETFs, and their options commission-free!About MRTX
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer.
MRTX Key Statistics
Stock Snapshot
Mirati Therapeutics(MRTX) stock is priced at $58.70, giving the company a market capitalization of 4.12B. It carries a P/E multiple of -4.80.
Mirati Therapeutics(MRTX) stock opened on 2026-04-05 at —. The price climbed to — and dipped to —.
The Mirati Therapeutics(MRTX)'s current trading volume is 0, compared to an average daily volume of 2.31M.
During the past year, Mirati Therapeutics(MRTX) stock moved between $27.30 at its lowest and $64.41 at its peak.
During the past year, Mirati Therapeutics(MRTX) stock moved between $27.30 at its lowest and $64.41 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.